This site is intended for healthcare professionals

account_circleSign in
Go to /sign-in page

You can view 5 more pages before signing in

Methods

Last reviewed dd mmm yyyy. Last edited dd mmm yyyy

Authoring team

The trial design was:

  • multicentre
  • randomised
  • double-blind
  • double-dummy

449 patients were enrolled into the trial within 30 hours from the onset of symptoms. Haemorrhagic stroke was excluded by a CT scan.

  • the aspirin group received 160 mg daily
  • LMWH group received 100 IU/kg twice daily

Patients were assessed at day 14 for:

  • recurrent stroke
  • secondary endpoints:
    • cerebral haemorrhage
    • progression of symptoms within the first 48 hrs
    • death

Create an account to add page annotations

Create a free account

Add information to this page that would be handy to have on hand during a consultation, such as a web address or phone number. This information will always be displayed when you visit this page